NASDAQ : IBIO
iBio, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.8136 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 52.32M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
iBio, Inc. (IBIO) reported revenue of 100.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Revenue | 100.00K | 100.00K | 400.00K | 225.00K | 1.88M | |
| Gross Profit | 100.00K | 100.00K | 400.00K | 225.00K | 1.88M | |
| Selling, General & Admin | 10.60M | 10.60M | 10.69M | 11.67M | 18.45M | 21.75M |
| Research & Development | 19.64M | 19.64M | 8.31M | 5.18M | 10.33M | 9.83M |
| Operating Expenses | 30.24M | 30.24M | 19.00M | 16.86M | 28.78M | 31.58M |
| Operating Income | -30.14M | -30.14M | -18.60M | -16.63M | -28.78M | -29.70M |
| Interest Expense | -53.00K | -53.00K | -212.00K | -172.00K | -83.00K | |
| Interest & Investment Income | 2.15M | 2.15M | 437.00K | 363.00K | 213.00K | 177.00K |
| Other Non Operating Income (Expenses) | 7.00K | |||||
| EBT Excluding Unusual Items | -28.04M | -28.04M | -18.38M | -16.44M | -28.65M | -29.51M |
| Gain (Loss) on Sale of Investments | -98.00K | |||||
| Gain (Loss) on Sale of Assets | 1.00M | |||||
| Asset Writedown | -5.00M | -5.00M | -565.00K | |||
| Pretax Income | -33.04M | -33.04M | -18.38M | -15.44M | -29.31M | -29.51M |
| Earnings From Continuing Operations | -33.04M | -33.04M | -18.38M | -15.44M | -29.31M | -29.51M |
| Earnings From Discontinued Operations | -9.46M | -35.70M | -20.79M | |||
| Net Income to Company | -33.04M | -33.04M | -18.38M | -24.91M | -65.01M | -50.30M |
| Minority Interest in Earnings | 1.00K | |||||
| Net Income | -33.04M | -33.04M | -18.38M | -24.91M | -65.01M | -50.30M |
| Preferred Dividends & Other Adjustments | 88.00K | |||||
| Net Income to Common | -33.04M | -33.04M | -18.38M | -24.91M | -65.01M | -50.39M |
| Shares Outstanding (Basic) | 104.06M | 104.06M | 10.50M | 3.83M | 612.00K | 436.05K |
| Shares Outstanding (Diluted) | 104.06M | 104.06M | 10.50M | 3.83M | 612.00K | 436.05K |
| EPS (Basic) | -0.32 | -0.32 | -1.75 | -6.50 | -106.23 | -115.56 |
| EPS (Diluted) | -0.32 | -0.32 | -1.75 | -6.50 | -106.23 | -115.56 |
| Free Cash Flow | -23.80M | -23.80M | -15.32M | -18.76M | -36.87M | -44.81M |
| Free Cash Flow Per Share | -0.23 | -0.23 | -1.46 | -4.90 | -60.24 | -102.76 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
| Operating Margin | -30,138.00% | -30,138.00% | -4,650.50% | -7,392.89% | -1,576.27% | |
| Profit Margin | -33,044.00% | -33,044.00% | -4,594.25% | -11,069.78% | -2,674.68% | |
| Free Cash Flow Margin | -23,796.00% | -23,796.00% | -3,830.00% | -8,339.56% | -2,378.45% | |
| EBITDA | -29.49M | -29.49M | -17.83M | -15.71M | -28.05M | -29.30M |
| D&A For EBITDA | 646.00K | 646.00K | 775.00K | 929.00K | 731.00K | 401.00K |
| EBIT | -30.14M | -30.14M | -18.60M | -16.63M | -28.78M | -29.70M |
Balance sheet
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 56.40M | 56.40M | 8.58M | 14.21M | 4.30M | 22.68M |
| Short-Term Investments | 31.64M | 31.64M | 10.85M | |||
| Cash & Short-Term Investments | 88.04M | 88.04M | 8.58M | 14.21M | 4.30M | 33.52M |
| Accounts Receivable | 1.00M | |||||
| Other Receivables | 105.00K | 204.00K | ||||
| Receivables | 1.10M | 1.10M | 105.00K | 713.00K | 204.00K | 1.00M |
| Prepaid Expenses | 3.08M | 3.08M | 1.03M | 749.00K | 664.00K | 1.55M |
| Restricted Cash | 3.02M | |||||
| Other Current Assets | 18.07M | 9.00M | ||||
| Total Current Assets | 92.22M | 92.22M | 9.72M | 15.67M | 26.26M | 45.07M |
| Property, Plant & Equipment | 4.75M | 4.75M | 5.28M | 6.37M | 7.55M | 4.44M |
| Other Intangible Assets | 1.82M | 1.82M | 6.85M | 5.37M | 5.39M | 4.85M |
| Other Long-Term Assets | 311.00K | 311.00K | 236.00K | 241.00K | 303.00K | 43.41M |
| Total Assets | 99.11M | 99.11M | 23.18M | 28.73M | 41.21M | 99.41M |
| Accounts Payable | 4.42M | 4.42M | 2.19M | 358.00K | 1.85M | 4.26M |
| Accrued Expenses | 5.63M | 5.63M | 1.34M | 2.03M | 4.56M | 3.76M |
| Short-Term Debt | 123.00K | 12.94M | 22.16M | |||
| Current Portion of Long-Term Debt | 766.00K | 218.00K | ||||
| Current Portion of Leases | 546.00K | 546.00K | 607.00K | 913.00K | 821.00K | 91.00K |
| Current Unearned Revenue | 1.15M | 1.15M | 1.20M | 200.00K | 100.00K | |
| Other Current Liabilities | 1.94M | 56.00K | ||||
| Total Current Liabilities | 11.74M | 11.74M | 6.11M | 3.84M | 22.11M | 30.44M |
| Long-Term Debt | 766.00K | |||||
| Long-Term Leases | 1.65M | 1.65M | 2.20M | 2.80M | 3.72M | 3.51M |
| Other Long-Term Liabilities | 1.97M | |||||
| Total Liabilities | 13.40M | 13.40M | 8.30M | 7.41M | 25.83M | 35.92M |
| Common Stock | 56.00K | 56.00K | 19.00K | 9.00K | 1.00K | 9.00K |
| Additional Paid-In Capital | 450.97M | 450.97M | 347.08M | 335.16M | 304.32M | 287.62M |
| Retained Earnings | -365.27M | -365.27M | -332.22M | -313.85M | -288.94M | -223.93M |
| Comprehensive Income & Other | -45.00K | -45.00K | -213.00K | |||
| Total Common Equity | 85.71M | 85.71M | 14.88M | 21.32M | 15.38M | 63.48M |
| Shareholders' Equity | 85.71M | 85.71M | 14.88M | 21.32M | 15.38M | 63.48M |
| Total Liabilities & Equity | 99.11M | 99.11M | 23.18M | 28.73M | 41.21M | 99.41M |
| Total Debt | 2.20M | 2.20M | 3.57M | 4.82M | 17.48M | 25.77M |
| Net Cash (Debt) | 85.84M | 85.84M | 5.01M | 9.39M | -13.17M | 7.75M |
| Net Cash Per Share | 0.82 | 0.82 | 0.48 | 2.45 | -21.53 | 17.78 |
| Filing Date Shares Outstanding | 64.31M | 64.31M | 19.65M | 8.64M | 1.38M | 450.33K |
| Total Common Shares Outstanding | 55.70M | 55.70M | 19.35M | 8.62M | 1.02M | 436.36K |
| Working Capital | 80.48M | 80.48M | 3.62M | 11.83M | 4.15M | 14.63M |
| Book Value Per Share | 1.54 | 1.54 | 0.77 | 2.47 | 15.15 | 145.49 |
| Tangible Book Value | 83.89M | 83.89M | 8.03M | 15.96M | 9.99M | 58.63M |
| Tangible Book Value Per Share | 1.51 | 1.51 | 0.42 | 1.85 | 9.84 | 134.37 |
| Buildings | 695.00K | 695.00K | 695.00K | 695.00K | 695.00K | |
| Machinery | 4.42M | 4.42M | 3.96M | 3.95M | 3.92M | |
| Construction In Progress | 24.00K | 24.00K | 1.37M |
Cash flow statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -33.04M | -33.04M | -18.38M | -24.91M | -65.01M | -50.30M |
| Depreciation & Amortization | 1.03M | 1.03M | 1.13M | 1.25M | 1.09M | 917.00K |
| Other Amortization | 120.00K | 242.00K | 107.00K | |||
| Loss (Gain) From Sale of Assets | 3.91M | -778.00K | ||||
| Asset Writedown & Restructuring Costs | 5.11M | 5.11M | 3.10M | 18.46M | ||
| Loss (Gain) From Sale of Investments | -194.00K | -194.00K | 165.00K | 2.07M | ||
| Stock-Based Compensation | 1.37M | 1.37M | 1.53M | 2.04M | 4.39M | 4.38M |
| Provision & Write-off of Bad Debts | 65.00K | 65.00K | ||||
| Other Operating Activities | -80.00K | -80.00K | -62.00K | -896.00K | 4.84M | -767.00K |
| Change in Accounts Receivable | -65.00K | -65.00K | 1.00M | -886.00K | ||
| Change in Inventory | -1.01M | -3.87M | ||||
| Change in Accounts Payable | 2.22M | 2.22M | 1.83M | -1.49M | -625.00K | 1.24M |
| Change in Unearned Revenue | -50.00K | -50.00K | 250.00K | 200.00K | -100.00K | 7.00K |
| Change in Other Net Operating Assets | 414.00K | 414.00K | -1.60M | -1.88M | 6.61M | 6.76M |
| Operating Cash Flow | -23.22M | -23.22M | -15.30M | -18.55M | -30.44M | -37.48M |
| Capital Expenditures | -578.00K | -578.00K | -16.00K | -210.00K | -6.43M | -7.33M |
| Sale of Property, Plant & Equipment | 116.00K | 2.60M | ||||
| Sale (Purchase) of Intangibles | 1.00M | -4.30M | ||||
| Investment in Securities | -31.50M | -31.50M | 10.84M | 6.50M | ||
| Other Investing Activities | 75.00K | 75.00K | 758.00K | |||
| Investing Cash Flow | -32.00M | -32.00M | 742.00K | 906.00K | 7.01M | -5.13M |
| Long-Term Debt Issued | 895.00K | 500.00K | ||||
| Short-Term Debt Repaid | -1.51M | -9.32M | ||||
| Long-Term Debt Repaid | -774.00K | -774.00K | -695.00K | -520.00K | -307.00K | -5.83M |
| Total Debt Repaid | -774.00K | -774.00K | -695.00K | -2.03M | -9.62M | -5.83M |
| Net Debt Issued (Repaid) | -774.00K | -774.00K | -695.00K | -1.14M | -9.12M | -5.83M |
| Issuance of Common Stock | 37.00M | 37.00M | 3.67M | 25.73M | 11.49M | 77.00K |
| Repurchase of Common Stock | -7.00K | -39.00K | ||||
| Other Financing Activities | 66.82M | 66.82M | 5.95M | -88.00K | -22.00K | -372.00K |
| Financing Cash Flow | 103.05M | 103.05M | 8.93M | 24.49M | 2.30M | -6.12M |
| Foreign Exchange Rate Adjustments | 33.00K | |||||
| Net Cash Flow | 47.83M | 47.83M | -5.63M | 6.85M | -21.09M | -48.73M |
| Free Cash Flow | -23.80M | -23.80M | -15.32M | -18.76M | -36.87M | -44.81M |
| Free Cash Flow Margin | -23,796.00% | -23,796.00% | -3,830.00% | -8,339.56% | -2,378.45% | |
| Free Cash Flow Per Share | -0.23 | -0.23 | -1.46 | -4.90 | -60.24 | -102.76 |
| Levered Free Cash Flow | -13.62M | -13.62M | -6.65M | 8.36M | -30.52M | -26.63M |
| Unlevered Free Cash Flow | -13.59M | -13.59M | -6.52M | 8.35M | -30.71M | -26.74M |
| Cash Interest Paid | 72.00K | 72.00K | 212.00K | 749.00K | 687.00K | 1.04M |
| Change in Working Capital | 2.52M | 2.52M | 479.00K | -3.17M | 5.87M | 3.24M |
Ratios
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 49.39M | 86.94M | 12.38M | 18.20M | 10.25M | 57.60M |
| Enterprise Value | -36.45M | 14.47M | 11.74M | 30.85M | 22.11M | 36.78M |
| Last Close Price | 0.77 | 1.75 | 0.76 | 2.11 | 12.20 | 132.00 |
| PS Ratio | 494.33 | 869.38 | 30.94 | 80.87 | 30.57 | |
| PB Ratio | 0.50 | 1.01 | 0.83 | 0.85 | 0.67 | 0.91 |
| P/TBV Ratio | 0.59 | 1.04 | 1.54 | 1.14 | 1.02 | 0.98 |
| EV/Sales Ratio | 144.66 | 29.34 | 137.12 | 19.52 | ||
| Debt / Equity Ratio | 0.03 | 0.03 | 0.24 | 0.23 | 1.14 | 0.41 |
| Net Debt / Equity Ratio | -1.00 | -1.00 | -0.34 | -0.44 | 0.86 | -0.12 |
| Net Debt / EBITDA Ratio | 2.91 | 2.91 | 0.28 | 0.60 | -0.47 | 0.27 |
| Net Debt / FCF Ratio | 3.61 | 3.61 | 0.33 | 0.50 | -0.36 | 0.17 |
| Asset Turnover | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | |
| Quick Ratio | 7.50 | 7.50 | 1.42 | 3.70 | 0.20 | 1.13 |
| Current Ratio | 7.85 | 7.85 | 1.59 | 4.08 | 1.19 | 1.48 |
| Return on Equity (ROE) | -65.70% | -65.70% | -101.52% | -84.15% | -74.33% | -34.31% |
| Return on Assets (ROA) | -30.80% | -30.80% | -44.79% | -29.73% | -25.58% | -15.07% |
| Return on Capital Employed (ROCE) | -34.50% | -34.50% | -108.90% | -66.80% | -150.70% | -43.10% |
| Earnings Yield | -41.34% | -38.01% | -148.48% | -136.88% | -634.44% | -87.34% |
| FCF Yield | -48.14% | -27.37% | -123.78% | -103.12% | -359.78% | -77.80% |
| Buyback Yield / Dilution | -891.14% | -891.14% | -174.05% | -525.98% | -40.35% | -11.45% |